| 臺大學術典藏 |
2022-03-10T05:59:29Z |
Reply to ‘Long-term use of acarbose and CV event: confusing finding from mega data bank’
|
Chang C.-H.; YI-CHENG CHANG; Lin J.-W.; Chuang L.-M. |
| 臺大學術典藏 |
2022-03-10T05:59:29Z |
No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan
|
Chang C.-H.; YI-CHENG CHANG; Lin J.-W.; Caffrey J.L.; Wu L.-C.; Lai M.-S.; Chuang L.-M. |
| 臺大學術典藏 |
2022-03-10T05:59:21Z |
Genome-wide association study for circulating fibroblast growth factor 21 and 23
|
Chuang G.-T.; Liu P.-H.; Chyan T.-W.; Huang C.-H.; Huang Y.-Y.; Lin C.-H.; Lin J.-W.; Hsu C.-N.; Tsai R.-Y.; Hsieh M.-L.; Lee H.-L.; Yang W.-S.; Robinson-Cohen C.; Hsiung C.-N.; Shen C.-Y.; YI-CHENG CHANG |
| 臺大學術典藏 |
2022-03-10T05:59:12Z |
Association between exosomal mirnas and coronary artery disease by next-generation sequencing
|
Chang S.-N.; Chen J.-J.; Wu J.-H.; Chung Y.-T.; Chen J.-W.; Chiu C.-H.; Liu C.-J.; Liu M.-T.; YI-CHENG CHANG; Li C.; Lin J.-W.; Hwang J.-J.; Lien W.-P. |
| 臺大學術典藏 |
2022-03-07T07:06:05Z |
Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure
|
Wu C.-K.; Luo J.-L.; Tsai C.-T.; Huang Y.-T.; Cheng C.-L.; JEN-KUANG LEE; Lin L.-Y.; Lin J.-W.; Hwang J.-J.; Chiang F.-T. |
| 臺大學術典藏 |
2022-03-07T07:06:05Z |
Association of low glomerular filtration rate and albuminuria with peripheral arterial disease: The National Health and Nutrition Examination Survey, 1999-2004
|
Wu C.-K.; Yang C.-Y.; Tsai C.-T.; Chiu F.-C.; Huang Y.-T.; JEN-KUANG LEE; Cheng C.-L.; Lin L.-Y.; Lin J.-W.; Hwang J.-J.; Chiang F.-T. |
| 臺大學術典藏 |
2022-03-07T07:06:04Z |
Insulin resistance in the middle-aged women with " Tigerish Back and Bearish Waist"
|
JEN-KUANG LEE; Wu C.-K.; Lin L.-Y.; Cheng C.-L.; Lin J.-W.; Hwang J.-J.; Chiang F.-T. |
| 臺大學術典藏 |
2022-03-07T07:06:03Z |
Metabolic syndrome, testosterone, and cardiovascular mortality in men
|
Lin J.-W.; JEN-KUANG LEE; Wu C.-K.; Caffrey J.L.; Chang M.-H.; Hwang J.-J.; Dowling N.; Lin Y.-S. |
| 臺大學術典藏 |
2022-03-07T07:06:00Z |
Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention
|
Chiu F.-C.; Wang T.-D.; JEN-KUANG LEE; Shih F.-Y.; Lin J.-W.; Huang C.-H.; Chen W.-J.; Chen M.-F. |
| 臺大學術典藏 |
2022-03-07T07:05:56Z |
The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling
|
Wu C.-K.; Yang C.-Y.; Lin J.-W.; Hsieh H.-J.; Chiu F.-C.; Chen J.-J.; JEN-KUANG LEE; Huang S.-W.; Li H.-Y.; Chiang F.-T.; Chen J.-J.; Tsai C.-T. |
| 臺大學術典藏 |
2022-03-07T07:05:53Z |
Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis
|
JEN-KUANG LEE; Lin H.-H.; Tsai C.-T.; Chen J.-J.; Kuo C.-C.; Lien Y.-C.; Lin J.-W.; Huang J.-W.; Hwang S.-W.; Hwang J.-J.; Tseng C.-D.; Chiang F.-T.; Chen J.-J.; Wu C.-K. |
| 臺大學術典藏 |
2022-03-07T07:05:52Z |
Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: A 12-year follow-up study
|
JEN-KUANG LEE; Wu C.-K.; Tsai C.-T.; Lin L.-Y.; Lin J.-W.; Chien K.-L.; Hwang J.-J.; Lin C.-L.; Tseng C.-D.; Chiang F.-T. |
| 臺大學術典藏 |
2022-03-07T07:05:45Z |
Prognostic factors of heart failure with preserved ejection fraction: A 12-year prospective cohort follow-up study
|
Wu C.-K.; JEN-KUANG LEE; Chiang F.-T.; Lin L.-Y.; Lin J.-W.; Hwang J.-J.; Tseng C.-D.; Tsai C.-T. |
| 臺大學術典藏 |
2022-03-07T07:05:43Z |
Measurement of visceral Fat: Should we include
|
Hung C.-S.; JEN-KUANG LEE; Yang C.-Y.; Hsieh H.-R.; Ma W.-Y.; Lin M.-S.; Liu P.-H.; Shih S.-R.; Liou J.-M.; Chuang L.-M.; Chen M.-F.; Lin J.-W.; Wei J.-N.; Li H.-Y. |
| 臺大學術典藏 |
2022-03-07T07:05:42Z |
Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis
|
Wu C.-K.; JEN-KUANG LEE; Wu Y.-F.; Tsai C.-T.; Chiang F.-T.; Hwang J.-J.; Lin J.-L.; Hung K.-Y.; Huang J.-W.; Lin J.-W. |
| 臺大學術典藏 |
2022-03-04T05:33:41Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Wu S.-G.; Chang Y.-L.; Lin J.-W.; CHEN-TU WU; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2022-03-01T08:19:54Z |
Comparing the survival between extracorporeal rescue and conventional resuscitation in adult in-hospital cardiac arrests: Propensity analysis of three-year data
|
Lin J.-W.; MING-JIUH WANG; Yu H.-Y.; Wang C.-H.; Chang W.-T.; Jerng J.-S.; Huang S.-C.; Chou N.-K.; Chi N.-H.; Ko W.-J.; Wang Y.-C.; Wang S.-S.; Hwang J.-J.; Lin F.-Y.; Chen Y.-S. |
| 臺大學術典藏 |
2022-02-15T03:21:46Z |
Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis
|
Lee J.-K.; Lin H.-H.; Tsai C.-T.; JIEN-JIUN CHEN; Kuo C.-C.; Lien Y.-C.; Lin J.-W.; Huang J.-W.; Hwang S.-W.; Hwang J.-J.; Tseng C.-D.; Chiang F.-T.; JIEN-JIUN CHEN; Wu C.-K. |
| 臺大學術典藏 |
2022-02-15T03:21:39Z |
Association between exosomal mirnas and coronary artery disease by next-generation sequencing
|
Chang S.-N.; JIEN-JIUN CHEN; Wu J.-H.; Chung Y.-T.; Chen J.-W.; Chiu C.-H.; Liu C.-J.; Liu M.-T.; Chang Y.-C.; Li C.; Lin J.-W.; Hwang J.-J.; Lien W.-P. |
| 臺大學術典藏 |
2022-02-14T07:10:33Z |
Investigating early progression of Hodgkin lymphoma in a two-center analysis
|
Yu T.-C.; SHAN-CHI YU; Wang R.-C.; Lai S.-F.; Teng C.-L.J.; Lin J.-W.; Lin W.-L.; Huang T.-C. |
| 臺大學術典藏 |
2022-01-24T09:32:09Z |
Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis
|
Liu C.-H.; Hsu S.-J.; Liang C.-C.; Tsai F.-C.; Lin J.-W.; CHUN-JEN LIU; Yang P.-M.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:09Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; Kao J.-H.; CHUN-JEN LIU; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:03Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:00Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Hsu S.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:58Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:56Z |
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
|
Liu C.-H.; Liang C.-C.; Huang K.-W.; CHUN-JEN LIU; Chen S.-I.; Lin J.-W.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:51Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:51Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:44Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:34Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:31:33Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; CHUN-JEN LIU; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:32Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:31:10Z |
Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals
|
Liu C.-H.; Lee M.-H.; Lin J.-W.; CHUN-JEN LIU; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-12T08:06:08Z |
Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study
|
Fu S.-H.; Wang C.-Y.; Hung C.-C.; CHIA-CHE LEE; Yang R.-S.; Huang C.-C.; Farn C.-J.; Lin W.-H.; Chen H.-M.; Hsiao F.-Y.; Lin J.-W.; Li C.-Y. |
| 臺大學術典藏 |
2022-01-07T06:05:52Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; CHIH-YUAN LEE; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 國立成功大學 |
2022 |
A Fast, Interactive, Location-Based Food Recommendation Application
|
Chiu, S.-M.;Chen, Y.-C.;Liou, Y.-S.;Lee, C.;Ying, J.-C.;Loh, C.-H.;Lin, J.-W. |
| 臺大學術典藏 |
2021-12-22T03:54:38Z |
The Impact of Lesion Length on Angiographic Restenosis after Vertebral Artery Origin Stenting
|
Lin Y.H.; Liu Y.C.; Tseng W.Y.I.; Juang J.M.; Hung C.S.; Lin J.W.; JIANN-SHING JENG; Yip P.K.; Kao H.L. |
| 臺大學術典藏 |
2021-12-02T02:26:11Z |
Association of amino-terminal pro-brain natriuretic peptide with metabolic syndrome
|
WEN-YI LI; Chiu F.-C.; Chien Y.-F.; Lin J.-W.; Hwang J.-J. |
| 臺大學術典藏 |
2021-12-02T02:26:11Z |
Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting
|
Huang T.-M.; Wu V.-C.; Young G.-H.; Lin Y.-F.; Shiao C.-C.; Wu P.-C.; WEN-YI LI; Yu H.-Y.; Hu F.-C.; Lin J.-W.; Chen Y.-S.; Lin Y.-H.; Wang S.-S.; Hsu R.-B.; Chang F.-C.; Chou N.-K.; Chu T.-S.; Yeh Y.-C.; Tsai P.-R.; Huang J.-W.; Lin S.-L.; Chen Y.-M.; Ko W.-J.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:30Z |
Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting
|
Huang T.-M.; VIN-CENT WU; Young G.-H.; Lin Y.-F.; Shiao C.-C.; Wu P.-C.; Li W.-Y.; Yu H.-Y.; Hu F.-C.; Lin J.-W.; Chen Y.-S.; Lin Y.-H.; Wang S.-S.; Hsu R.-B.; Chang F.-C.; Chou N.-K.; Chu T.-S.; Yeh Y.-C.; Tsai P.-R.; Huang J.-W.; Lin S.-L.; Chen Y.-M.; Ko W.-J.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:54:26Z |
Kidney impairment in primary aldosteronism
|
VIN-CENT WU; Yang S.-Y.; Lin J.-W.; Cheng B.-W.; Kuo C.-C.; Tsai C.-T.; Chu T.-S.; Huang K.-H.; Wang S.-M.; Lin Y.-H.; Chiang C.-K.; Chang H.-W.; Lin C.-Y.; Lin L.-Y.; Chiu J.-S.; Hu F.-C.; Chueh S.-C.; Ho Y.-L.; Liu K.-L.; Lin S.-L.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-08T02:52:22Z |
Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
|
Wu J.-H.; Chang S.-N.; Nishida T.; BO-I KUO; Lin J.-W. |
| 臺大學術典藏 |
2021-10-08T08:16:23Z |
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer
|
MONG-WEI LIN; Su K.-Y.; Su T.-J.; Chang C.-C.; Lin J.-W.; Lee Y.-H.; Yu S.-L.; Chen J.-S.; Hsieh M.-S. |
| 臺大學術典藏 |
2021-09-04T06:18:56Z |
Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases
|
Liu C.-H.; Lin J.-W.; Tsai F.-C.; Yang P.-M.; Lai M.-Y.; Chen J.-H.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:18:54Z |
The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events
|
Dai D.-F.; Lin J.-W.; JIA-HORNG KAO; Hsu C.-N.; Chiang F.-T.; Lin J.-L.; Chou Y.-H.; Hsu K.-L.; Tseng C.-D.; Tseng Y.-Z.; Hwang J.-J. |
| 臺大學術典藏 |
2021-09-04T06:12:36Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; JIA-HORNG KAO; Liu C.-J.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:12:35Z |
Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis
|
Liu C.-H.; Hsu S.-J.; Liang C.-C.; Tsai F.-C.; Lin J.-W.; Liu C.-J.; Yang P.-M.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:12:27Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:21Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Hsu S.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:14Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
